Nidan Laboratories and Healthcare shareholders and shareholding pattern
NSE: NIDANHealthcare Services
Nidan Laboratories and Healthcare Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 2021 · Issue price ₹125
Last close ₹13.00₹0.00 (0.00%)
Share price at the NSE close on 29 Oct 2026. Previous close ₹13.00.
29 Oct: open ₹13.00, high ₹13.00, low ₹13.00
52-week range of traded prices to 29 Oct 2026
₹11.50Low, 25 Jun 2026₹24.90High, 1 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹18 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 12.00
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.26
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.16
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,000100.0% delivered
Nidan Laboratories and Healthcare's shareholding pattern for Sep 2026, filed on 7 Oct 2026, with every filing from Mar 2022: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Nidan Laboratories and Healthcare, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters57.04%
- Individuals and others42.96%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Individuals and others
| Per cent | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.22% | 71.22% | 71.22% | 62.79% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% | |
| Indian promoters | 71.22% | 71.22% | 71.22% | 62.79% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 28.79% | 28.78% | 28.78% | 37.21% | 42.96% | 42.96% | 42.96% | 42.96% | 42.96% | 42.96% | 42.96% | 42.96% |
| Shares in issue | 1,39,00,000 | 1,39,00,000 | 1,39,00,000 | 1,39,00,000 | 1,39,00,000 | 1,39,00,000 | 1,39,00,000 | 1,39,00,000 | 1,39,00,000 | 1,39,00,000 | 1,39,00,000 | 1,39,00,000 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 98,99,400 | 99,00,000 | 27,95,500 | 27,95,500 | 27,95,500 | 27,95,500 | 0 | – | – | – | – | – |
| Promoters' shares locked in | 98,99,400 | 98,99,400 | 27,95,500 | 27,95,500 | 27,95,500 | 27,95,500 | 0 | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Nidan Laboratories and Healthcare promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is NITIN VITTHALRAO THORVE, 50.15%.Promoter buying and selling
| Holder | ||
|---|---|---|
| NITIN VITTHALRAO THORVEIndividuals and Hindu undivided families | 50.15% | 69,70,500 |
| ROSHAN NITIN THORVEIndividuals and Hindu undivided families | 6.89% | 9,57,200 |
| ABHILASHA NITIN THORAVEIndividuals and Hindu undivided families | 0.00% | 100 |
| EDWIN FRANCIS DABREIndividuals and Hindu undivided families | 0.00% | 100 |
| HARIPRIT NITIN THORAVEIndividuals and Hindu undivided families | 0.00% | 100 |
| KRUPESH DEEPAK THAKURIndividuals and Hindu undivided families | 0.00% | 100 |
| LATA VITTHAL HANDEIndividuals and Hindu undivided families | 0.00% | 100 |
| TEJAL ANIL JAYAKARIndividuals and Hindu undivided families | 0.00% | 100 |
| VITTHAL LAXMAN THORAVEIndividuals and Hindu undivided families | 0.00% | 100 |
No promoter shares are reported as pledged.
Largest public holders of Nidan Laboratories and Healthcare, filing by filing
Per cent, on the same shares as the split above.
| Holder | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RAMEGOWDA SONNENAHALLI OMPRAKASH GOWDAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | 1.06% | 1.10% | 1.12% | 1.18% |
| DEVENDRA RAJNIKANT LADHANIResident individuals, over ₹2 lakh at face value | – | – | – | – | 1.08% | 1.08% | 1.08% | 1.08% | 1.08% | 1.08% | 1.08% | 1.08% |
| KHUSHI ADVERTISING IDEAS PRIVATE LIMITEDCompanies | – | 1.15% | – | – | – | – | – | – | – | – | – | – |
| FIRST OVERSEAS CAPITAL LIMITEDOther non-institutions | 1.01% | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: RAMEGOWDA SONNENAHALLI OMPRAKASH GOWDA 1.18%, +0.06 pts